Myocarditis with Immune Checkpoint Blockade
Myocarditis with Immune Checkpoint Blockade
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
In their report on cardiotoxicity associated with immune checkpoint blockade, Johnson et al. (Nov. 3 issue)
1
describe two patients with melanoma in whom fatal myocarditis developed after treatment with ipilimumab and nivolumab. In addition, other cases of cardiotoxicity associated with such treatment have been reported.
...
Alternative Titles
Full title
Myocarditis with Immune Checkpoint Blockade
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1861578224
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1861578224
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1615251
